Cargando…
Drug-Resistant Tuberculosis in High-Risk Groups, Zimbabwe
To estimate prevalence of multidrug-resistant tuberculosis (MDR TB) in Harare, Zimbabwe, in 2012, we performed microbiologic testing on acid-fast bacilli smear-positive sputum samples from patients previously treated for TB. Twenty (24%) of 84 specimens were consistent with MDR TB. A national drug-r...
Autores principales: | Metcalfe, John Z., Makumbirofa, Salome, Makamure, Beauty, Sandy, Charles, Bara, Wilbert, Mungofa, Stanley, Hopewell, Philip C., Mason, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3884722/ https://www.ncbi.nlm.nih.gov/pubmed/24377879 http://dx.doi.org/10.3201/eid2001.130732 |
Ejemplares similares
-
Microscopic-Observation Drug-Susceptibility Assay for the Diagnosis of Drug-Resistant Tuberculosis in Harare, Zimbabwe
por: Makamure, Beauty, et al.
Publicado: (2013) -
Prevalence of Extensively Drug Resistant Tuberculosis among Archived Multidrug Resistant Tuberculosis Isolates in Zimbabwe
por: Sagonda, Tichaona, et al.
Publicado: (2014) -
Health care seeking patterns of rifampicin-resistant tuberculosis patients in Harare, Zimbabwe: A prospective cohort study
por: Tadokera, Rebecca, et al.
Publicado: (2021) -
Comparison of two active case-finding strategies for community-based diagnosis of symptomatic smear-positive tuberculosis and control of infectious tuberculosis in Harare, Zimbabwe (DETECTB): a cluster-randomised trial
por: Corbett, Elizabeth L, et al.
Publicado: (2010) -
Drug-Resistant Tuberculosis, Lebanon, 2016 – 2017
por: El Achkar, Salam, et al.
Publicado: (2019)